(10-006) From Stabilization to Silencing: Assessing Adherence and Outcomes of Tafamidis and Vutrisiran in Patients with Cardiac Amyloidosis in a Rural Setting
Wednesday, December 10, 2025
11:00 AM - 12:00 PM
Location: Bayside A, Level 1
Residency Program: John D. Archbold Memorial Hospital Residency Program Type: PGY1 (Pharmacy) Residency Program Location: Georgia
